Rocco D. Spagnuolo - Publications

Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 05, 2026

Current management of acute severe ulcerative colitis in Italy: Results from an IG-IBD survey.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 22, 2026

Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study.

Journal: Advances in therapy

Published: March 21, 2026

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

Journal: Advances in therapy

Published: February 11, 2026

Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation.

Journal: Frontiers in cell and developmental biology

Published: December 24, 2025

Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 11, 2025